Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHFAN vs BHFAL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BHFAN Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 5–4 Matrix Metrics)

BHFAN Overall Winner 6-Pillar Tally: BHFAN 3 – 1 BHFAL (2 Tie) Matrix Metrics: BHFAN 5 – 4 BHFAL

As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058 (BHFAL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BHFAN carries a Unified Composite Score of 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin), whereas BHFAL carries 52.5/100 (HOLD) at $14.61 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While BHFAL currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. BHFAN 33.7/100 SELL), BHFAN captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 0.0% operating margin) and revenue trajectory (-52.7% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHFAN vs BHFAL
BHFAN NASDAQ Head-to-Head Winner
Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C
Life Insurance
$9.18
-0.65% 1D
Market Cap N/A
TTM Revenue $5.81B
Forward P/E N/M
Beta / 30D Vol 0.36β · 16% Vol
Unified Composite Score
33.7 / 100 SELL
Tech 18.0 Fund 37.0 Flow 50.0 Mom 49.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.0%), weak momentum, RSI 18
RSI-14: 17.9 · SMA20: $10.09 · SMA50: $10.65
BHFAL NASDAQ
Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058
Life Insurance
$14.61
-0.51% 1D
Market Cap $3.4B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.15β · 22% Vol
Unified Composite Score
52.5 / 100 HOLD
Tech 67.0 Fund 58.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.6%), weak momentum, RSI 41
RSI-14: 41.5 · SMA20: $14.95 · SMA50: $15.12

6-Pillar Scorecard Institutional Category Breakdown (BHFAN 3 – 1 BHFAL)

Columns: Metric · BHFAN · BHFAL
1. Valuation Multiples BHFAN
Forward P/E N/M N/M
Trailing P/E 0.7x N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale BHFAL
Revenue Growth (YoY) -52.7% +0.0%
Earnings Growth (YoY) -34.0% +0.0%
TTM Revenue (USD) $5.81B N/A
Market Cap N/A $3.4B
3. Profitability & Quality BHFAN
Gross Margin 16.5% N/A
Operating Margin 18.4% 0.0%
Net Profit Margin 11.7% 0.0%
Return on Equity (ROE) 11.9% 0.0%
4. Balance Sheet & Cash Flow BHFAN
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $87.13 Book/Sh · 11.9% ROE 0.0% ROE
Dividend Yield 14.25% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Life Operator Other Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHFAN (5) vs BHFAL (4)
Institutional Metric BHFAN BHFAL Criterion Row Edge
Market Capitalization
Scale
N/A $3.4B Larger Scale BHFAL
Trailing P/E Ratio
Valuation
0.7x N/M Lower Multiple BHFAN
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-52.7% +0.0% Higher Growth BHFAL
Operating Margin (TTM)
Profitability
18.4% 0.0% Higher Margin BHFAN
Net Profit Margin
Profitability
11.7% 0.0% Higher Margin BHFAN
Return on Equity (ROE)
Capital Efficiency
11.9% 0.0% Higher ROE BHFAN
52-Week Range Position
Momentum
0% ($9–$14) 2% ($14–$19) Stronger Trend BHFAL
Beta / 30D Volatility
Risk Regime
0.36β · 16% Vol 0.15β · 22% Vol Lower Realized Risk BHFAN
Unified Institutional Score
Composite Signal
33.7 / 100 (SELL) 52.5 / 100 (HOLD) Higher Composite BHFAL
Trailing 12M Revenue (USD)
Operating Scale
$5.81B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($87.13 Book/Sh · 11.9% ROE) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHFAL +10.13 pp
BHFAN: -12.24% · BHFAL: -2.11%
3M Horizon BHFAL +11.83 pp
BHFAN: -21.4% · BHFAL: -9.57%
6M Horizon BHFAL +14.1 pp
BHFAN: -26.85% · BHFAL: -12.75%
1Y Horizon BHFAL +13.79 pp
BHFAN: -29.0% · BHFAL: -15.21%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHFAN vs BHFAL. Trailing 12-month operating profitability (BHFAN 18.4% vs BHFAL 0.0%) and valuation multiples (BHFAN N/M vs BHFAL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BHFAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.81B
Gross Margin16.5%
Op. Margin18.4%
ROE / Fwd P/E11.9% · N/M
BHFAL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHFAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHFAL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHFAL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHFAN Moat Profile Scale & Operating Efficiency Moat
Insurance - Life Operator
Competes within the Insurance - Life value chain with N/A market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BHFAL Moat Profile Cyclical / Execution-Driven Positioning
Other Operator
Competes within the Other value chain with $3.4B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BHFAN vs BHFAL Key Questions & Quantitative Answers

As of Nov 20, 2026, Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) is the stronger overall head-to-head candidate over Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058 (BHFAL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). BHFAN carries a Unified Composite Score of 33.7/100 (SELL) at $9.18 (N/M Forward P/E, 18.4% operating margin), whereas BHFAL carries 52.5/100 (HOLD) at $14.61 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While BHFAL currently prints a higher short-term Unified Composite Score (52.5/100 HOLD vs. BHFAN 33.7/100 SELL), BHFAN captures the overall institutional head-to-head verdict (5–4 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (18.4% vs. 0.0% operating margin) and revenue trajectory (-52.7% vs. +0.0% YoY). Technical & Structure Timing Caution: BHFAN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9); meanwhile BHFAL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHFAL leads the Growth & Scale pillar: BHFAN posts -52.7% YoY revenue growth and -34.0% YoY earnings growth on $5.81B TTM revenue (16.5% gross margin, 18.4% operating margin), compared with BHFAL at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BHFAN generates $5.81B in USD-normalized revenue versus N/A for BHFAL. In operating R&D and SG&A reinvestment, BHFAN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BHFAL.

BHFAN screens cheaper on headline valuation multiples. BHFAN trades at N/M Forward P/E, 0.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BHFAL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHFAN (11.9% ROE) versus BHFAL (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BHFAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.36β · 16% Vol realized risk). By comparison, BHFAL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.15β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Brighthouse Financial, Inc. Depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN) Research Suite

Brighthouse Financial, Inc. 6.25% Junior Subordinated Debentures due 2058 (BHFAL) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.